BE709012A - - Google Patents

Info

Publication number
BE709012A
BE709012A BE709012DA BE709012A BE 709012 A BE709012 A BE 709012A BE 709012D A BE709012D A BE 709012DA BE 709012 A BE709012 A BE 709012A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE709012A publication Critical patent/BE709012A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE709012D 1967-01-10 1968-01-05 BE709012A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR90478A FR6087M (cg-RX-API-DMAC7.html) 1967-01-10 1967-01-10
FR133258A FR6934M (cg-RX-API-DMAC7.html) 1967-01-10 1967-12-21

Publications (1)

Publication Number Publication Date
BE709012A true BE709012A (cg-RX-API-DMAC7.html) 1968-05-16

Family

ID=26174501

Family Applications (1)

Application Number Title Priority Date Filing Date
BE709012D BE709012A (cg-RX-API-DMAC7.html) 1967-01-10 1968-01-05

Country Status (13)

Country Link
US (1) US3542870A (cg-RX-API-DMAC7.html)
AT (1) AT278750B (cg-RX-API-DMAC7.html)
BE (1) BE709012A (cg-RX-API-DMAC7.html)
CH (1) CH485658A (cg-RX-API-DMAC7.html)
DE (1) DE1668930C3 (cg-RX-API-DMAC7.html)
DK (1) DK120400B (cg-RX-API-DMAC7.html)
ES (1) ES349044A1 (cg-RX-API-DMAC7.html)
FI (1) FI48067C (cg-RX-API-DMAC7.html)
FR (2) FR6087M (cg-RX-API-DMAC7.html)
GB (1) GB1146139A (cg-RX-API-DMAC7.html)
SE (1) SE349020B (cg-RX-API-DMAC7.html)
SU (1) SU456406A3 (cg-RX-API-DMAC7.html)
YU (1) YU34272B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1273A (en) 1980-07-09 1985-03-08 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
US6650943B1 (en) 2000-04-07 2003-11-18 Advanced Bionics Corporation Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction
US6885895B1 (en) * 2001-04-26 2005-04-26 Advanced Bionics Corporation Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
CA2558126A1 (en) * 2004-03-17 2005-09-29 Sosei R&D Ltd. The treatment of inflammatory disorders and pain using beta-aminoalcohols
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661372A (en) * 1953-12-01 Pharmacologically valuable stereo
GB789033A (en) * 1954-10-23 1958-01-15 Philips Nv Improvements in or relating to substituted aralkyl-phenyl-alkylamines
FR1165845A (fr) * 1955-05-28 1958-10-29 Philips Nv Amines secondaires portant des substituants et leur préparation
GB800718A (en) * 1955-05-28 1958-09-03 Philips Nv Novel substituted alkylamines and processes for their production
BE630296A (cg-RX-API-DMAC7.html) * 1962-03-31
NL130079C (cg-RX-API-DMAC7.html) * 1963-06-28
FR3654M (fr) * 1963-11-08 1965-11-02 Raymond Michel β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.

Also Published As

Publication number Publication date
FR6087M (cg-RX-API-DMAC7.html) 1968-06-04
FI48067B (cg-RX-API-DMAC7.html) 1974-02-28
US3542870A (en) 1970-11-24
YU34272B (en) 1979-04-30
AT278750B (de) 1970-02-10
DK120400B (da) 1971-05-24
GB1146139A (en) 1969-03-19
FR6934M (cg-RX-API-DMAC7.html) 1969-05-05
SU456406A3 (ru) 1975-01-05
CH485658A (fr) 1970-02-15
YU4668A (en) 1978-10-31
DE1668930B2 (de) 1973-08-02
ES349044A1 (es) 1969-08-16
DE1668930A1 (de) 1971-09-16
FI48067C (fi) 1974-06-10
DE1668930C3 (de) 1974-02-28
SE349020B (cg-RX-API-DMAC7.html) 1972-09-18

Similar Documents

Publication Publication Date Title
AU5765369A (cg-RX-API-DMAC7.html)
FI48067B (cg-RX-API-DMAC7.html)
AU416737B2 (cg-RX-API-DMAC7.html)
AU2277767A (cg-RX-API-DMAC7.html)
AU342066A (cg-RX-API-DMAC7.html)
AU2528767A (cg-RX-API-DMAC7.html)
AU2977667A (cg-RX-API-DMAC7.html)
AU3151267A (cg-RX-API-DMAC7.html)
AU3189468A (cg-RX-API-DMAC7.html)
AU610966A (cg-RX-API-DMAC7.html)
BE614676A (cg-RX-API-DMAC7.html)
BE710478A (cg-RX-API-DMAC7.html)
BE609934A (cg-RX-API-DMAC7.html)
BE609869A (cg-RX-API-DMAC7.html)
BE509738A (cg-RX-API-DMAC7.html)
BE483855A (cg-RX-API-DMAC7.html)
BE477645A (cg-RX-API-DMAC7.html)
BE711807A (cg-RX-API-DMAC7.html)
BE711545A (cg-RX-API-DMAC7.html)
BE426053A (cg-RX-API-DMAC7.html)
BE162295A (cg-RX-API-DMAC7.html)
AU97666A (cg-RX-API-DMAC7.html)
BE692198A (cg-RX-API-DMAC7.html)
BE692199A (cg-RX-API-DMAC7.html)
BE711375A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LABORATOIRES HOUDE

Effective date: 19880105